A higher proportion of CD8+ T cells was observed in TP63-low tumor samples (median = 52.29%) than TP63-high tumors (median = 40.07%) (Fig. 3C, D and Supplementary Fig. 4D). This evidence concerns the gene CD8A and neoplasm.